Abstract:This review will focus on the free radical signaling mechanism of preconditioning. The results from our laboratory as well as studies from other laboratories suggest that reactive oxygen species function as second messenger during myocardial adaptation to ischemia. This review provides evidence for the first time that tyrosine kinase and MAP kinases are the targets for reactive oxygen species generated in the preconditioned myocardium. The finding that p38 MAP kinase might be upstream of NF kappa B further sup… Show more
“…of either those enzymes that directly cause DNA fragmentation, such as calcium-and magnesium-dependent endonuclease (DNase I), or proteins that regulate signal transduction leading to apoptosis, such as calcineurin, calpain and nuclear scaffold protease (Peitsch et al, 1993;McConkey & Orrenius, 1997;Gottlieb & Engler, 1999). Calcium overloading also increases free radical generation (Bagchi et al, 1997), a well-defined apoptosis-inducing factor (Das et al, 1999). Moreover, in cell culture systems, addition of dihydropyridine calcium channel blockers, amlodipine and nifedipine, reduces excessive apoptosis in aging cerebellar granule cells (Mason et al, 1999) and in hypoxic neonatal rat cardiac myocytes (Chen et al, 1998).…”
1 Considerable evidence indicates that calcium plays a critical role in apoptosis. We have previously shown that benidipine, a vasodilatory calcium channel blocker, attenuates postischemia myocardial apoptosis. The present study was designed to determine the mechanisms by which benidipine exerts its antiapoptotic effect. 2 Adult male rats were subjected to 30 min of ischemia followed by 3 h of reperfusion. Rats were randomized to receive either vehicle or benidipine (10 mg kg À1 , i.v.) 10 min before reperfusion. 3 Compared with rats receiving vehicle, those rats treated with benidipine had reduced postischemic myocardial apoptosis as evidenced by decreased TUNEL-positive staining (8.471.2 vs 15.371.3%, Po0.01) and caspase-3 activity (1.9470.25 vs 3.4370.29, Po0.01). 4 Benidipine treatment significantly reduced mitochondrial cytochrome c release and caspase-9 activation, but had no effect on caspase-8 activation, suggesting that benidipine exerts its antiapoptotic effect by inhibiting the mitochondrial-mediated, but not death receptor-mediated, apoptotic pathway. 5 Benidipine treatment not only increased the maximal activity of ERK1/2 at 10 min after reperfusion, but also prolonged the duration of ERK1/2 activation. Benidipine treatment had no significant effect on other apoptotic regulating molecules, such as p38 MAPK. 6 Taken together, our present study demonstrated for the first time the differential regulation of a calcium channel blocker. Benidipine tilted the balance between ERK1/2 and p38 MAPK toward an antiapoptotic state, decreased mitochondrial cytochrome c release, reduced caspase-9 activation, and attenuated subsequent caspase-3 activation and postischemic myocardial apoptosis.
“…of either those enzymes that directly cause DNA fragmentation, such as calcium-and magnesium-dependent endonuclease (DNase I), or proteins that regulate signal transduction leading to apoptosis, such as calcineurin, calpain and nuclear scaffold protease (Peitsch et al, 1993;McConkey & Orrenius, 1997;Gottlieb & Engler, 1999). Calcium overloading also increases free radical generation (Bagchi et al, 1997), a well-defined apoptosis-inducing factor (Das et al, 1999). Moreover, in cell culture systems, addition of dihydropyridine calcium channel blockers, amlodipine and nifedipine, reduces excessive apoptosis in aging cerebellar granule cells (Mason et al, 1999) and in hypoxic neonatal rat cardiac myocytes (Chen et al, 1998).…”
1 Considerable evidence indicates that calcium plays a critical role in apoptosis. We have previously shown that benidipine, a vasodilatory calcium channel blocker, attenuates postischemia myocardial apoptosis. The present study was designed to determine the mechanisms by which benidipine exerts its antiapoptotic effect. 2 Adult male rats were subjected to 30 min of ischemia followed by 3 h of reperfusion. Rats were randomized to receive either vehicle or benidipine (10 mg kg À1 , i.v.) 10 min before reperfusion. 3 Compared with rats receiving vehicle, those rats treated with benidipine had reduced postischemic myocardial apoptosis as evidenced by decreased TUNEL-positive staining (8.471.2 vs 15.371.3%, Po0.01) and caspase-3 activity (1.9470.25 vs 3.4370.29, Po0.01). 4 Benidipine treatment significantly reduced mitochondrial cytochrome c release and caspase-9 activation, but had no effect on caspase-8 activation, suggesting that benidipine exerts its antiapoptotic effect by inhibiting the mitochondrial-mediated, but not death receptor-mediated, apoptotic pathway. 5 Benidipine treatment not only increased the maximal activity of ERK1/2 at 10 min after reperfusion, but also prolonged the duration of ERK1/2 activation. Benidipine treatment had no significant effect on other apoptotic regulating molecules, such as p38 MAPK. 6 Taken together, our present study demonstrated for the first time the differential regulation of a calcium channel blocker. Benidipine tilted the balance between ERK1/2 and p38 MAPK toward an antiapoptotic state, decreased mitochondrial cytochrome c release, reduced caspase-9 activation, and attenuated subsequent caspase-3 activation and postischemic myocardial apoptosis.
“…Indeed, blockade of ROS production decreases the protection afforded by preconditioning. [38][39][40][41][42] Metabolic dysfunction is also a likely contributor to preconditioning. Decline in the ATP/ADP ratio leads to opening of mitochondrial K ATP channels, 43 and activation of these channels increases ROS generation.…”
Section: Caspase Activation In Neuroprotection/ischemic Tolerancementioning
Caspases are a family of cysteine proteases that are expressed as inactive zymogens and undergo proteolytic maturation in a sequential manner in which initiator caspases cleave and activate the effector caspases 3, 6 and 7. Effector caspases cleave structural proteins, signaling molecules, DNA repair enzymes and proteins which inhibit apoptosis. Activation of effector, or executioner, caspases has historically been viewed as a terminal event in the process of programmed cell death. Emerging evidence now suggests a broader role for activated caspases in cellular maturation, differentiation and other non-lethal events. The importance of activated caspases in normal cell development and signaling has recently been extended to the CNS where these proteases have been shown to contribute to axon guidance, synaptic plasticity and neuroprotection. This review will focus on the adaptive roles activated caspases in maintaining viability, the mechanisms by which caspases are held in check so as not produce apoptotic cell death and the ramifications of these observations in the treatment of neurological disorders.
“…Reactive oxygen species produced by an oxidizing environment likely increase the opening of K ATP channels via modification of thiol residues within the channels and thus establishing a positive feedback loop for protection (Forbes et al, 2001;Grigoriev et al, 1999;Pain et al, 2000). Preconditioning protection can be blocked with antioxidants and K ATP channel blockers (Baines et al, 1997;Das et al, 1999;Forbes et al, 2001;Lebuffe et al, 2003;Ravati et al, 2001). We hypothesize the major importance of K ATP channel opening during mild ischemia is to enhance the generation of ROS (McLaughlin, 2004(McLaughlin, , 2003.…”
Section: The Clinical Realities Of Diabetes and Ischemia Vulnerabilitymentioning
The phenomenon of ischemic preconditioning was initially observed over 20 years ago. The basic tenant is that if stimuli are applied at a subtoxic level, cells upregulate endogenous protective mechanisms to block injury induced by subsequent stress. Since this discovery, many conserved signaling mechanisms that contribute to activation of this potent protective program have been identified in the brain. A clinical correlate of this basic research finding can be found in patients with a history of transient ischemic attack (TIA), who have a decreased morbidity after stroke. In spite of multidisciplinary efforts to design safer, more effective stroke therapies, we have thus far failed to translate our understanding of endogenous protective pathways to treatments for neurodegeneration. This review is designed to provide clinicians and basic scientists with an overview of stress biology after TIA and preconditioning, discuss new therapeutic strategies to target the protein dysfunction that follows ischemic injury, and propose enhanced biochemical profiling to identify individuals at risk of stroke after TIA. We pay particular attention to the unanticipated consequences of overly aggressive intervention after TIA in which we have found that traditional cytotoxic agents such as free radicals and apoptosis associated proteases is essential for neuroprotection and communication in the stressed brain. These data emphasize the importance of understanding the complex interplay between chaperones, apoptotic proteases including caspases, and the proteolytic degradation machinery in adaptation to neurological injury.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.